Immune memory has been explained according to three basic schemes: (a) altered handling of antigen due to combination with antibody or due to the ability of macrophages to degrade antigen more effectively; (b) expansion of a done of reactive ceils, the daughter cells being identical to the original antigen-sensitive cells (1-3); and (c) differentiation of a unique class of "memory cells" which react more rapidly and effectively on antigen contact than the original antigen-sensitive cells (4-7). In this paper we examine the establishment of short-term memory to distinguish between these hypotheses. We define memory as the capacity to give a greater and more rapid response to a second injection of antigen than to a first injection. In the response of mice to sheep erythrocytes (SRBC), measured by the hemolytic plaque assay (8), early IgM memory arises within the 1st day, approximately 2 days before any substantial increase in direct plaques (9). IgM memory continues to increase during the 1st wk after the primary injection (9, 10).
with scalpels in Eagle's minimal essential medium without bicarbonate (pH adjusted to 7.4 with NaOH). The suspension was passed through two stainless steel screens, 80 and 250 mesh, respectively. Nucleated cells were counted in a hemacytometer after dilution into a hemolytic agent, 0.01% gentian violet, 2% acetic acid. In most experiments, the total volume of the cell suspension was recorded in order to calculate the plaques per spleen.
Hemolytic Assays.--Hemolytic plaque assays were performed by a modification of the technique of Jerne and Nordin (8) . To 0.75 ml 0.7% agarose, dissolved in Eagle's minimal essential medium, were added 0.04 m120% washed sheep erythrocytes, 0.04 ml guinea pig serum (complement), and a variable amount of spleen cell suspension. This mixture was poured onto a 1.4% agarose-Eagle's minimal essential medium underlayer in a 50 mm Petri dish and incubated 2-3 hr at 37°C. Plaques were counted by indirect light.
RESULTS

Early IgM Memory.--Memory is defined as the number of plaques resulting
from two injections of antigen minus the sum of the plaques expected from either injection alone. Our standard dose regimen was an injection of 2 X 10 e SRBC ("low" dose), followed at varying intervals by an injection of 4 X l0 s SRBC ("high" dose). The total response and the calculated memory for several dose regimens are shown in Table I . The primary response to either the high or the low dose alone is included for reference. Also included axe our code designations for each group.
During the first 2 days of the response to either dose alone, there is little increase in the number of direct plaques (see groups 2L and 2H in Table I ). During this period, however, the mice have become able to respond much more rapidly and vigorously to a second dose of antigen; that is, they have been primed. Comparing group 1,2 with groups receiving only the primary injection (3L) or only the secondary injection (2H), it is apparent that the injections elicit a far greater response in combination than alone. The memory increases further during the 2nd day after primary injection: the memory value is larger for group 2,2 than for group 1,2 (see reference 9).
Cell Division and the Immune Response.--We employed methotrexate (MTX), a folio acid antagonist, to prevent cell division. Folinic acid (leueovorin = LV) was injected 24 hr after MTX in an attempt to prevent further inhibition and increase the general health of the animals, although most of the MTX should have been excreted by this time (13) . LV is an effective antidote when administered simultaneously with MTX but has little effect when administered 1 day later (Table II, and reference 14) .
There is a striking contrast between the first and subsequent days of the response of mice to SRBC. MTX administered simultaneously with antigen (or before antigen) does not inhibit the response to a high dose of SRBC (Table  II) . However, MTX administered after 1 or 2 days have elapsed greatly diminishes the plaque number. The same disparity between the first and subsequent days is apparent in the response to a low dose of SRBC; MTX administered In a series, the primary injection is a low dose and the secondary, high, unless otherwise indicated. For example, mice in group 2,2 received 2 X l0 s SRBC on day 0, 4 X l0 s SRBC on day 2, and were killed day 4.
§ "Memory" was calculated by subtracting from the plaques obtained the sum of all plaques expected as a result of either injection alone. This is not applicable in groups receiving only one injection.
simultaneously with antigen (on day 0) has no effect, but MTX administered on day 1, 2, or 3 decreases the 4-day plaque response 8-to 15-fold (Fig. 1, A) .
Cell Division and the Establishment of Memory.--The effect of MTX on the establishment of short-term memory was examined in mice which received a second antigenic challenge 2 days after the primary injection. MTX was administered on day 0, 1, 2, or 3 relative to the primary injection, and the response was measured on day 4 ( Fig. 1, B) . Two conclusions can be drawn from this experiment. (a) MTX does inhibit the events occurring within 24 hr after a secondary injection of antigen. This is in contrast to its lack of effect during the 1st day of a primary response. (b) Priming, like the primary response itself, be- comes susceptible to MTX 1 day after the initial antigen injection. MTX administered at the time of the initial injection had no effect on the ability of mice to respond to a second dose of antigen, but MTX injected 1 day after antigen diminished the response to a second injection given on day 2. The experiment shown in Fig. 1 , B suggested that priming has two phases: a nonproliferative phase, approximately 1 day long, followed by a proliferative phase. To confirm the nonproliferative nature of the first phase, we altered the regimen, administering the second injection of SRBC just 1 day after the primary injection. When MTX was administered along with the primary injection, the 1 day priming was not inhibited (Table III) .
Although there is no doubt that MTX inhibits proliferation, its metabolic effects are not restricted to inhibition of thymidine synthesis (11) . To support our contention that the inhibitory effect of MTX is due to prevention of cell division, we did some preliminary experiments employing hydroxyurea, a drug which inhibits DNA synthesis quite specifically (15) Specificity of Memory.--To show that memory was specific for the priming antigen we performed the experiments presented in Table IV . Preinjection with burro erythrocytes, which cross-react only slightly with sheep or goat erythrocytes, has no effect on the subsequent 2-day response to sheep RBC (Table IV, * Both groups of mice received 2 X 108 SRBC on day 0 and 4 X l0 s SRBC on day 1. The plaque assay was performed on day 3.
Mice received 25 mg/kg body weight methotrexate, intraperitoneally, at the same time as the first antigen injection, and 35 mg/kg leucovorin a few hours before the second injection of SRBC. a and b). During a specific secondary response to burro erythrocytes, there is a slight stimulation of the response to sheep or goat erythrocytes (Table IV, d and f). The increment is small, however, compared with specific memory (Table   IV , g).
TABLE IV
Antigen Specifwity of Short-Term Memory
Time of Assay.--After a short priming interval, the secondary IgM response reaches a very sharp peak between the 2nd and 3rd days (9), a fact which some have overlooked. To avoid inaccuracy caused by missing this sharp peak, we measured the response before the peak in all cases. Thus we may be measuring the delay or diminution of the peak response, or some combination of the two. Both effects have been noted by Rivarola, et al. (16) depending upon the dose regimen of MTX. In limited experiments, we found no evidence of delay. Either delay or diminution, however, would be a valid measure of inhibition of the response.
DISCUSSION
During the 1st day after primary antigen injection, a mouse does not produce detectable plaque-forming cells, but it does develop the ability to respond with rapid proliferation and antibody production to a second injection of antigen. Methotrexate has no effect on the priming which occurs during the 1st day. During the 2nd day after injection of SRBC, the short-term memory continues to increase; this increase can be inhibited by MTX. Priming thus has two phases: the first, comprising approximately 1 day, does not require cell division, but rather some qualitative change in cells; the second consists of proliferation of some or all of these altered cells.
The phases which we have measured separately as the responses to two injections of antigen may be identical to those normally occurring in the primary response. The greater rapidity and magnitude of the primary response to a large dose of antigen (Table I , and references 9 and 17) can be explained as follows. The first contact of antigen-sensitive cells (X cells) with antigen leads to development of cells (Y cells) which are capable of reacting to further antigen contact by very rapid proliferation and production of antibody (9) . In our system, the opportunity for further antigen contact is minimal after the low primary dose, unless a second injection is given. After the hig/~ primary dose, enough antigen will remain to induce nearly maximal division and antibody production. This view is supported by our findings, shown in Table I , that (a) mice receiving a second dose 1 day after the low primary dose respond as well as animals receiving the high primary dose; (b) a second injection 1 day after the high primary injection causes only a small enhancement of the response; and (c) even the low doses, if given dally, can induce a vigorous response. None of these findings is predicted by the hypothesis that cells, once triggered, respond in a predetermined manner for a predetermined time and can no longer be affected by antigen contact. Clearly, the IgM-producing cell is still responsive to further antigenic contact (19, 20, 10 ). An injection just before the peak of a secondary IgM response can prolong the increase of IgM plaques (21) .
Radioautographic examination of plaque-forming cells which have been exposed to isotopically labeled thymidine in vitro or in vivo have led to various conclusions. Some authors have concluded that a large proportion of PFC pres-ent 3 or 4 days after antigenic stimulation have not synthesized a complement of DNA at any time since the antigen administration (22, 23) . Other studies have indicated that all plaque-forming cells arise from dividing precursors after the 2nd day (24, 25) . Most of these studies have not been designed to measure the rate of division. Those which have attempted to measure the cell cycle time have not agreed: Koros et al. (18) found a generation time of approximately 7 hr, while Tannenberg calculated 13 hr (26) .
Studies utilizing inhibitors of replication are difficult to interpret, owing to the problems of dosage, morbidity, and indirect effects. We have tried to avoid this problem insofar as possible by limiting the duration of the drug effect. Most inhibition studies indicate that cell division is necessary for the increase in plaque-forming ceils (27) (28) (29) (30) . Rowley et al. measured the disappearance of plaques after administration of vinblastine or colchicine, and found a cell cycle time, approximately equal to the plaque number doubling time, of 5-10 hr after the 2nd day of the response (31) . Perhaps the clearest demonstration that cell division is required for the immune response is that of Dutton and Mishell (32) who caused dividing ceils to incorporate a lethal dose of tritiated thymidine, thereby preventing a response by cultured mouse spleen ceils, unless the "hot pulse" was restricted to the 1st day after antigen administration. Uyeki (33) showed that MTX inhibits the response in vivo if given on the 2nd day after antigen administration, but not if given along with antigen, and we have found the same.
Our evidence indicates a qualitative difference between the ceils which respond to primary and secondary injections; i.e., X and Y cells. On the basis of entirely different evidence, others have come to the same conclusion (34, 35) . We have found that a second administration of antigen within a few days after the prlm~ug dose causes plaque-forming ceils to increase rapidly. The considerable increase which occurs within 1 day is due to proliferation, as it is inhibited by methotrexate. On the contrary, events of the 1st day after the primary injection of SRBC are not inhibited by methotrexate nor by hydroxyurea.
Apparently, the preparatory events of the 1st day postprimary need not be repeated after the second injection. These events undoubtedly include macrophage processing and distribution of antigen, although these processes probably require only a short time, on the order of 1 hr (36) (37) (38) . Other events may include preparation for division, interaction of thymus-derived and bone marrowderived cells (39) , and morphological changes (40, 41) . We have suggested that (additional) receptor molecules synthesized during the 1st day might mediate an interaction of ceils and antigen leading to immediate proliferation (9) .
We emphasize that the immediate proliferative response to reinjection of antigen applies to short-term IgM memory only. Short-term memory wanes approximately 1 month after priming (9, 10) . Recently described phenomena in other systems (42, 43) parallel our finding, but are not exactly comparable.
However, the results of O'Brien and Coons (44) and our own preliminary resuits indicate that the secondary response after long priming intervals includes a nonproliferative lag phase. We are currently engaged in experiments designed to confirm or deny the existence of two varieties of IgM memory, and to compare IgM and IgG memory.
SUMM~.RY
Short-term IgM memory is established within I day after primary injection. This I day priming is independent of cell division as it can take place in the pressence d methotrexate or hydroxyurea.
The primary response involves a similar I day nonproliferative phase. On the contrary, cells responding to a second injection of antigen after short priming intervals begin to proliferate within hours. This implies a qualitative difference between the antigen-sensitive ceils in primed and normal animals.
After I day, further proliferative expansion of memory can occur, which is probably antigen dependent. The response to several dose regimens indicates that repeated antigenic contact is needed to maintain the IgM response.
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